User profiles for Shirsajit Mitra

Shirsajit Mitra

Research Scholar, KaviKrishna Laboratory, IIT Guwahati
Verified email at student.amity.edu
Cited by 36

[HTML][HTML] Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome

…, A Nandi, A Sinha, S Kar, N Manoharan, S Mitra… - Biomedicine & …, 2022 - Elsevier
The Host-microbiome interactions that exist inside the gut microbiota operate in a synergistic
and abnormal manner. Additionally, the normal homeostasis and functioning of gut …

[HTML][HTML] The emerging role of oral microbiota in oral cancer initiation, progression and stemness

PJ Saikia, L Pathak, S Mitra, B Das - Frontiers in Immunology, 2023 - frontiersin.org
Oral squamous cell carcinoma (OSCC) is the most prevalent malignancy among the Head
and Neck cancer. OSCCs are highly inflammatory, immune-suppressive, and aggressive …

[HTML][HTML] Targeting hypoxia-induced tumor stemness by activating pathogen-induced stem cell niche defense

S Bhuyan, B Pal, L Pathak, PJ Saikia, S Mitra… - Frontiers in …, 2022 - frontiersin.org
Tumor hypoxia and oxidative stress reprograms cancer stem cells (CSCs) to a highly
aggressive and inflammatory phenotypic state of tumor stemness. Previously, we characterized …

A novel comprehensive Tuberculosis (TB) control programme methodology based on the nexus of participatory action research inspired public health and precision …

S Mitra, PJ Saikia, A Dutta, R Das, G Das, T Baishya… - medRxiv, 2024 - medrxiv.org
Tuberculosis is emerging as a major global health issue for the under-developed regions
across the world including India's North East. Importantly, the incidence of multidrug-resistant (…

[HTML][HTML] 90 Circulating altruistic stem cells as a marker of immunosuppression in oral cancer

L Pathak, S Bhuyan, B Pal, P Saikia, S Gayan, S Mitra… - 2022 - jitc.bmj.com
Background Head & neck cancer is the 4th cancer, and most of them are diagnosed late, and
treated with cisplatin monotherapy. In these subsets of patients, immunotherapy has been …

Oral microbiome reprograms oral cancer stem cells to the highly immunosuppressive tumor stemness defense (TSD) phenotype

PJ Saikia, L Pathak, S Mitra, B Das - Cancer Research, 2023 - AACR
Oral squamous cell carcinoma (OSCC) is a global health disease affecting developing
countries, mainly the South and South East Asian countries. This cancer type is mostly HPV-16 …

Fusobacterium nucleatum present in the saliva of oral cancer subjects can activate niche defense of oral squamous cell carcinoma

PJ Saikia, L Pathak, S Mitra, IS Akeel, B Pal, T Baishya… - bioRxiv, 2023 - biorxiv.org
Oral cancer is a subset of head and neck cancer (HNC), has a high incidence rate in this
malignancy group. Cancer Stem Cells (CSCs) are population of the heterogeneous malignant …

Targeting tumor stemness switch phenotype by activating pathogen induced stem cell niche defense

S Bhuyan, B Pal, L Pathak, PJ Saikia, S Mitra, S Gayan… - bioRxiv, 2022 - biorxiv.org
Cancer stem cells (CSCs) reside in their tumor microenvironment (TME) niches, which are
often hypoxic. Previously, we found that hypoxia and oxidative stress prevalent in TME may …

Reducing cancer disparity among indigenous people by locally prepared Whey protein isolates having selective cytoprotective ability against chemotherapy induced …

NR Das, L Pathak, B Pal, R Das, PJ Saikia, S Mitra… - Cancer Research, 2024 - AACR
Background: Cancer disparity is a major problem for the indigenous people living in the rural
area of Kamrup district of Assam, a remote north eastern state of India. Often, rural people …

Fusobacterium nucleatum in saliva of oral cancer patients induces tumor stemness defense phenotype in cancer stem cells

PJ Saikia, B Pal, L Pathak, S Mitra, T Baishya, R Das… - Cancer Research, 2024 - AACR
122: Fusobacterium nucleatum in saliva of oral cancer patients induces tumor stemness
defense phenotype in cancer stem cells | Cancer Research | American Association for Cancer …